Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...
Into that heaven of freedom, my Father, let my country awake.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果